Vaccines for pandemic influenza /
| Other Authors: | , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
Berlin :
Springer,
[2009]
|
| Series: | Current topics in microbiology and immunology ;
v. 333. |
| Subjects: |
Table of Contents:
- Part I. Pandemic Influenza Overview
- Pandemic influenza as a current threat
- Antigenic cross-reactivity among H5N1 Viruses
- Part II. Current Approaches for Human and Avian Vaccine Production
- Seasonal influenza vaccines
- Generation and characterization of candidate vaccine viruses for pre-pandemic influenza vaccines
- Live attenuated vaccines for pandemic influenza
- Influenza vaccines for avian species
- Development and application of avian influenza vaccines in China
- Part III. Novel Vaccine Approaches
- Designing vaccines for pandemic influenza
- Attenuated influenza virus vaccines with modified NS1 proteins
- DNA Vaccines against Influenza viruses
- Recombinant proteins produced in insect cells
- Influenza neuraminidase as a vaccine antigen
- Recombinant vectors as influenza vaccines
- Influenza virus-like particles as pandemic vaccines
- Pandemic influenza vaccines
- Adjuvants for pandemic influenza vaccines
- Part IV. Novel Approaches of Vaccine Delivery
- Transcutaneous immunization with influenza vaccines
- Microneedle-based vaccines
- Part V. Vaccine Evaluation, Production and Distribution
- Animal models for evaluation of influenza vaccines
- Immunosenescence and influenza vaccine efficacy
- Vaccines for pandemic influenza: summary of recent clinical trials
- Considerations for licensure of influenza vaccines with pandemic and pre-pandemic indications
- Strategies for broad global access to pandemic influenza
- Prioritization of pandemic influenza vaccine: rationale and strategy for decision-making